Condition
Bedsore
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Terminated2
Recruiting1
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07193849Phase 4Recruiting
Zinc Oxide VS MEBO
NCT02412046Not ApplicableTerminated
Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics
NCT03114345Not ApplicableTerminated
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
NCT02055729CompletedPrimary
Changes in Bacterial Flora Among Patients With Pelvic Bedsores: a Prospective Pilot Study
Showing all 4 trials